MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes
Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG …

Read more on News-Medical-Net